Drug Profile
Lamivudine/tenofovir disoproxil fumarate + nevirapine - Aurobindo Pharma
Alternative Names: Tenofovir disoproxil fumarate/lamivudine + nevirapine - Aurobindo PharmaLatest Information Update: 11 Dec 2018
Price :
$50
*
At a glance
- Originator Aurobindo Pharma
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Cyclopropanes; Deoxyribonucleosides; Dideoxynucleosides; Phosphonic acids; Purines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections
Most Recent Events
- 11 Dec 2018 Chemical structure information added
- 28 Nov 2018 Lamivudine/tenofovir disoproxil fumarate co-packaged with nevirapine is not yet avaliable in USA for HIV-1 infections (Aurobindo Pharma website, November 2018)